Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lavender Bina Cendikia Tbk. (BMBL) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Lavender Bina Cendikia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Lavender Bina Cendikia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp30 (market cap 30.9B, 2.96M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 5.4× Lavender Bina Cendikia Tbk.'s market cap, and Lavender Bina Cendikia Tbk. is more actively traded (2.96M versus 71K). Which is the better fit depends on your goals.

BMBLOBAT
Market Cap
30.9B167.37B
Volume
2.96M71K
Lot
29.64K710
Turnover
88.75M17.51M
Average Price
29.94246.63
Value
88.75M17.51M
Indicative Equilibrium Price
30246
Indicative Equilibrium Volume
11

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMBL
View details
OBAT
View details

About Lavender Bina Cendikia Tbk.

PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.

Read more on BMBL

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT